Boar’s Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst

Boar’s Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst


Boar’s Head announced Friday it has indefinitely shut down a Virginia deli meat plant and discontinuing the liverwurst that is linked to a deadly multi-state listeria outbreak that also sickened dozens.

In what it called a “dark moment” in the company’s history, Boar’s Head said in a Friday statement it’s indefinitely closing its plant in Jarratt, Virginia, where the liverwurst product connected to the outbreak was made.

The cause of the contamination was a “specific production process” that only existed at the Jarratt facility, the company said.

“We regret and deeply apologize for the recent Listeria monocytogenes contamination in our liverwurst product. We understand the gravity of this situation and the profound impact it has had on affected families,” the statement said.

“We have made the difficult decision to indefinitely close this location, which has not been operational since late July 2024. It pains us to impact the livelihoods of hundreds of hard-working employees,” the company said.

“We do not take lightly our responsibility as one of the area’s largest employers,” the statement continues. “But, under these circumstances, we feel that a plant closure is the most prudent course. We will work to assist each of our employees in the transition process.”

This year’s liverwurst outbreak killed nine and hospitalized 57. Boar’s Head recalled its Strassburger Brand Liverwurst on July 25 over concerns it contained the bacterium Listeria monocytogenes.

The CDC said the company was responsible for the largest listeriosis outbreak since 2011, when more than 30 people died from affected cantaloupe.

The recall was expanded to include 7 million pounds of meat, which the company said was every item produced at the facility.

The United States Department of Agriculture on July 31 gave the Jarratt facility a notice of suspension.

According to records from the USDA, the Virginia plant had dozens of violations that included reports of inspectors finding insects, mold and puddles of blood.

Department personnel logged 69 instances of noncompliance with federal regulations at the plant from Aug. 1, 2023, through Aug. 2, 2024, according to documents CBS News obtained through federal Freedom of Information Act requests.

According to the documents, the Agriculture Department reported “heavy discolored meat build up” on a hydraulic pump in the plant and on the motor of an inspection line on Aug. 8, 2023, and again reported “heavy meat buildup” on walls of a room in the plant on June 10.

The presence of insects was also an issue at the plant, according to department.

Flies were found “going in and out” of pickle vats on June 10, and “small flying gnat like insects were observed crawling on the walls and flying around the room.” The department also reported a “steady line of ants” and “a presence of flying insects” in the same room, according to the documents. Also reported on the same day were “7 ladybugs, 1 beetle like insect, and 1 cockroach like insect.”

Boar’s Head said since its voluntary recall in late July, it has worked with the USDA and state government regulatory agencies and leading food safety experts to learn what went wrong and make improvements.

Some increased measures, according to Boar’s Head, include: Appointing a new chief food safety officer who will report directly to the company’s president; launching a food safety council comprised of independent food safety experts; and creating an enhanced and companywide food safety and QA program, Boar’s Head said.

Gallup recently found that Americans’ faith in the government’s ability to provide safe food in its food supply has reached a record low since 1999.



Source

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Health

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 […]

Read More
Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval
Health

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in […]

Read More
Eli Lilly earnings are coming Thursday. Here’s what top analysts expect
Health

Eli Lilly earnings are coming Thursday. Here’s what top analysts expect

Many on Wall Street expect that Novo Nordisk ‘s loss has been Eli Lilly ‘s gain, and this will be good news for the Zepbound maker’s second-quarter results. Novo Nordisk’s stock has cratered about 47% since the start of the year, as doubts emerged about the outlook for its GLP-1 drugs, Ozempic for diabetes and […]

Read More